desoxycorticosterone has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amann, K; Cordasic, N; Hartner, A; Hilgers, KF; Klanke, B; Schmieder, RE; Veelken, R | 1 |
1 other study(ies) available for desoxycorticosterone and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Statin treatment reduces glomerular inflammation and podocyte damage in rat deoxycorticosterone-acetate-salt hypertension.
Topics: Animals; Blood Pressure; Cell Proliferation; Desoxycorticosterone; Disease Progression; Fatty Acids, Monounsaturated; Fluvastatin; Glomerulonephritis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Indoles; Kidney; Male; Nephrosclerosis; Organ Size; Podocytes; Rats; Rats, Sprague-Dawley | 2009 |